MSH|^~\&|LAB|ARH|||201912161228||ORU^R01|4129416|D|2.3|||AL|NE PID|1||AB00007953|AB7905|LABTEST^ABBY^|||F||||||||||AB000026/19| OBR|1|36744^LAB|00027863^1612:C00004R^LAB^161219:C4^36744|522.1390^PROG17^17-alpha-hydroxyprogesterone^^^XXX-0791||201912161019|201912161019|||||||201912161019||||||||||LAB|F|||| OBX|1|ST|522.1400^PROG17 R^17-alpha-hydroxyprogesterone^^X500^XXX-0791|1|10.0^^Y|nmol/L||N||A^S|F|||201912161228 NTE|1||17-OH progesterone reference ranges: NTE|2||F/M 15D- 1Y <3.4 nmol/L NTE|3||F/M 1-7Y <1.0 nmol/L NTE|4||F/M Prepubertal <1.0 nmol/L NTE|5||M 17-100y <6.0 nmol/L NTE|6|| NTE|7||F Follicular <2.4 nmol/L NTE|8||F Luteal <8.6 nmol/L NTE|9||F Post-Menopausal <1.5 nmol/L OBR|2|36744^LAB|00027863^1612:C00004R^LAB^161219:C4^36744|522.2290^ANDROS^Androstenedione^^^XXX-0712||201912161019|201912161019|||||||201912161019||||||||||LAB|F|||| OBX|1|ST|522.2300^ANDROS R^Androstenedione^^X500^XXX-0712|1|20.000^^Y|nmol/L||N||A^S|F|||201912161113 NTE|1||Androstenedione reference ranges: NTE|2||Female/Male: NTE|3||<14D <2.54 nmol/L NTE|4||14D-365D <5.7 nmol/L NTE|5||1-5Y <0.568 nmol/L NTE|6||6-9Y <0.917 nmol/L NTE|7||10-11Y <2.54 nmol/L NTE|8|| NTE|9||Female: NTE|10||12-14Y 0.74-6.01 nmol/L NTE|11||15-18Y 0.48-6.45 nmol/L NTE|12||>18Y Pre-menopausal 0.91-7.47 nmol/L NTE|13|| Post-menopausal 0.45-2.86 nmol/L NTE|14|| NTE|15||Male: NTE|16||12-14Y 0.51-2.01 nmol/L NTE|17||15-18Y 0.87-3.55 nmol/L NTE|18||>18Y 0.80-3.11 nmol/L